Jae Park, MD - MSK Leukemia Specialist ...

Dr. Jae Park, MD

Claim this profile

Memorial Sloan Kettering Cancer Center

Studies Acute Lymphoblastic Leukemia
Studies Leukemia
14 reported clinical trials
27 drugs studied

Area of expertise

1

Acute Lymphoblastic Leukemia

Jae Park, MD has run 6 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:

CD19 positive
Philadelphia chromosome positive
Philadelphia chromosome negative
2

Leukemia

Jae Park, MD has run 5 trials for Leukemia. Some of their research focus areas include:

CD19 positive
Philadelphia chromosome negative
Philadelphia chromosome positive

Affiliated Hospitals

Image of trial facility.

Memorial Sloan Kettering Cancer Center

Image of trial facility.

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Clinical Trials Jae Park, MD is currently running

More about Jae Park, MD

Clinical Trial Related

6 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Jae Park, MD has experience with

  • Dexamethasone
  • Cyclophosphamide
  • Dasatinib
  • Venetoclax
  • Obinutuzumab
  • Vemurafenib

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Jae Park, MD specialize in?

Is Jae Park, MD currently recruiting for clinical trials?

Are there any treatments that Jae Park, MD has studied deeply?

What is the best way to schedule an appointment with Jae Park, MD?

What is the office address of Jae Park, MD?

Is there any support for travel costs?